Noelia Victoria Miret (Miret Noelia)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Cells

Signaling Pathway

Chemotherapy Induced

Endoplasmic Reticulum Stress

Top Venues

Molecular carcinogenesis

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yamila Sanchez, Mariana Abigail Vasquez Callejas, Noelia Victoria Miret, Gabino Rolandelli, Catalina Costas, Andrea Silvana Randi, Alejandro J Español
Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells. Exploration of targeted anti-tumor therapy 5 (2) (2024)
Yamila Sanchez, Mariana Abigail Vasquez Callejas, Noelia Victoria Miret, Gabino Rolandelli, Catalina Costas, Andrea Silvana Randi, Alejandro J Español
Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells. Exploration of targeted anti-tumor therapy 5 (2) (2024)
Zahira Deza, Giselle Romero Caimi, Noelia Victoria Miret, Lucia Coli, Viviana E Ré, Laura Alvarez
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF-β1/pERK signaling pathway. Molecular carcinogenesis 62 (3) (2022)
Zahira Deza, Giselle Romero Caimi, Noelia Victoria Miret, Lucia Coli, Viviana E Ré, Laura Alvarez
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF-β1/pERK signaling pathway. Molecular carcinogenesis (2022)
Zahira Deza, Giselle Romero Caimi, Noelia Victoria Miret, Lucia Coli, Viviana E Ré, Laura Alvarez
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF-β1/pERK signaling pathway. Molecular carcinogenesis 62 (3) (2022)
Zahira Deza, Giselle Romero Caimi, Noelia Victoria Miret, Lucia Coli, Viviana E Ré, Laura Alvarez
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF-β1/pERK signaling pathway. Molecular carcinogenesis 62 (3) (2022)
Zahira Deza, Giselle Romero Caimi, Noelia Victoria Miret, Lucia Coli, Viviana E Ré, Laura Alvarez
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF-β1/pERK signaling pathway. Molecular carcinogenesis 62 (3) (2022)